ConductScience.org, home

Paper75815

Islet cell survival determined by morphology. An immunocytochemical study of the islets of Langerhans in juvenile diabetes mellitus.

Gepts W and 1 other. Diabetes, 1978. Cited by 202 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Islet cell survival determined by morphology. An immunocytochemical study of the islets of Langerhans in juvenile diabetes mellitus. Papers, record 75815. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/75815

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Islet cell survival determined by morphology. An immunocytochemical study of the islets of Langerhans in juvenile diabetes mellitus.
PubMed
Journal
Diabetes
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
202
iCite
Relative citation ratio, by iCite
4.75
iCite
Revised in PubMed
2019-05-15
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gepts WW
2De Mey JJ

Source PubMed

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetes Mellitus, Type 1Major topic
Islets of LangerhansMajor topic
Adolescent
Adult
Cell Count
Child
Child, Preschool
Female
Histocytochemistry
Humans
Infant
Male
Staining and Labeling

Source PubMed

Cited by76

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 202 citations.

PMIDTitleJournalYearIn PapersSource
42,327,161AI-guided analysis of human pancreatic islet sociology reveals distinct cell compositional changes in type 1 diabetes.bioRxiv2026https://conductscience.org/library/papers/42327161PubMed
39,337,311Adropin Is Expressed in Pancreatic Islet Cells and Reduces Glucagon Release in Diabetes Mellitus.Int J Mol Sci2024https://conductscience.org/library/papers/39337311PubMed
39,283,482β-Cell Heterogeneity and Plasticity.Adv Anat Embryol Cell Biol2024https://conductscience.org/library/papers/39283482PubMed
38,922,355Loss of insulin-expressing extra-islet cells in type 1 diabetes is accompanied with increased number of glucagon-expressing extra-islet cells.Virchows Arch2025https://conductscience.org/library/papers/38922355PubMed
36,346,618An Early Islet Transcriptional Signature Is Associated With Local Inflammation in Autoimmune Diabetes.Diabetes2023https://conductscience.org/library/papers/36346618PubMed
34,115,115A human mutation in STAT3 promotes type 1 diabetes through a defect in CD8+ T cell tolerance.J Exp Med2021https://conductscience.org/library/papers/34115115PubMed
32,802,890Two to Tango: Dialogue between Adaptive and Innate Immunity in Type 1 Diabetes.J Diabetes Res2020https://conductscience.org/library/papers/32802890PubMed
32,324,170Pancreas tissue slices from organ donors enable in situ analysis of type 1 diabetes pathogenesis.JCI Insight2020https://conductscience.org/library/papers/32324170PubMed
31,839,487New Frontiers in the Treatment of Type 1 Diabetes.Cell Metab2020https://conductscience.org/library/papers/31839487PubMed
30,767,048Beta cells in type 1 diabetes: mass and function; sleeping or dead?Diabetologia2019https://conductscience.org/library/papers/30767048PubMed
30,293,191Pancreas Pathology During the Natural History of Type 1 Diabetes.Curr Diab Rep2018https://conductscience.org/library/papers/30293191PubMed
30,073,765Persistent elevations in circulating INS DNA among subjects with longstanding type 1 diabetes.Diabetes Obes Metab2019https://conductscience.org/library/papers/30073765PubMed
28,959,234Type I Interferon Is a Catastrophic Feature of the Diabetic Islet Microenvironment.Front Endocrinol (Lausanne)2017https://conductscience.org/library/papers/28959234PubMed
28,951,820Human beta cell mass and function in diabetes: Recent advances in knowledge and technologies to understand disease pathogenesis.Mol Metab2017https://conductscience.org/library/papers/28951820PubMed
28,763,258Cyclin D2 is sufficient to drive β cell self-renewal and regeneration.Cell Cycle2017https://conductscience.org/library/papers/28763258PubMed
28,323,930β Cells Persist in T1D Pancreata Without Evidence of Ongoing β-Cell Turnover or Neogenesis.J Clin Endocrinol Metab2017https://conductscience.org/library/papers/28323930PubMed
28,223,284Mafa Enables Pdx1 to Effectively Convert Pancreatic Islet Progenitors and Committed Islet α-Cells Into β-Cells In Vivo.Diabetes2017https://conductscience.org/library/papers/28223284PubMed
28,099,204Narrowing in on the anti-β cell-specific T cells: looking 'where the action is'.Curr Opin Endocrinol Diabetes Obes2017https://conductscience.org/library/papers/28099204PubMed
27,591,120Cellular senescence: Implications for metabolic disease.Mol Cell Endocrinol2017https://conductscience.org/library/papers/27591120PubMed
26,013,143miR-375 gene dosage in pancreatic β-cells: implications for regulation of β-cell mass and biomarker development.J Mol Med (Berl)2015https://conductscience.org/library/papers/26013143PubMed

See all 76 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/75815

GET https://conductscience.org/api/papers/v1/75815/cited_by?page=2